AU2001233928A1 - Cvd assay - Google Patents

Cvd assay

Info

Publication number
AU2001233928A1
AU2001233928A1 AU2001233928A AU3392801A AU2001233928A1 AU 2001233928 A1 AU2001233928 A1 AU 2001233928A1 AU 2001233928 A AU2001233928 A AU 2001233928A AU 3392801 A AU3392801 A AU 3392801A AU 2001233928 A1 AU2001233928 A1 AU 2001233928A1
Authority
AU
Australia
Prior art keywords
assay
cobalamin
cardiovascular disease
cvd
holo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233928A
Other languages
English (en)
Inventor
Lars Orning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axis Shield ASA
Original Assignee
Axis Shield ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axis Shield ASA filed Critical Axis Shield ASA
Publication of AU2001233928A1 publication Critical patent/AU2001233928A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Optical Head (AREA)
  • Gyroscopes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
AU2001233928A 2000-02-21 2001-02-21 Cvd assay Abandoned AU2001233928A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0004040.2A GB0004040D0 (en) 2000-02-21 2000-02-21 Assay
GB0004040 2000-02-21
PCT/GB2001/000747 WO2001063298A2 (en) 2000-02-21 2001-02-21 Diagnosis of cvd measuring folate and holo-tcii

Publications (1)

Publication Number Publication Date
AU2001233928A1 true AU2001233928A1 (en) 2001-09-03

Family

ID=9886094

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233928A Abandoned AU2001233928A1 (en) 2000-02-21 2001-02-21 Cvd assay

Country Status (12)

Country Link
US (1) US20040253745A1 (da)
EP (1) EP1257831B1 (da)
JP (1) JP2003524186A (da)
AT (1) ATE325345T1 (da)
AU (1) AU2001233928A1 (da)
CY (1) CY1105520T1 (da)
DE (1) DE60119289T2 (da)
DK (1) DK1257831T3 (da)
ES (1) ES2262627T3 (da)
GB (1) GB0004040D0 (da)
PT (1) PT1257831E (da)
WO (1) WO2001063298A2 (da)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133951A (en) * 1975-05-08 1979-01-09 The Radiochemical Centre Limited Vitamin B-12 cobalt-57 and process
US4273757A (en) * 1977-06-02 1981-06-16 Yissum Research Development Company Determination of transcobalamins
US4418151A (en) * 1981-03-30 1983-11-29 Rohm And Haas Company Assay process with non-boiling denaturation
US4680273A (en) * 1985-07-29 1987-07-14 Victor Herbert Assay for vitamin B12 deficiency
US5715835A (en) * 1992-11-19 1998-02-10 Anticancer, Inc. Methods for treating and reducing the potential for cardiovascular disease using methioninase compositions
DE19647352C2 (de) * 1996-11-15 2000-06-29 Aqua Nova Getraenketechnologie Nicht alkoholisches Getränk mit einem Gehalt an Q 10
CA2335588A1 (en) * 1998-06-29 2000-01-06 Edwin F. Ullman Assay for homocysteine
JP2002523749A (ja) * 1998-08-20 2002-07-30 アクシス シールド エイエスエイ 心血管疾患のためのアッセイ方法

Also Published As

Publication number Publication date
PT1257831E (pt) 2006-08-31
CY1105520T1 (el) 2010-07-28
ATE325345T1 (de) 2006-06-15
US20040253745A1 (en) 2004-12-16
DE60119289D1 (de) 2006-06-08
GB0004040D0 (en) 2000-04-12
DE60119289T2 (de) 2007-04-19
DK1257831T3 (da) 2006-08-28
EP1257831B1 (en) 2006-05-03
WO2001063298A2 (en) 2001-08-30
WO2001063298A3 (en) 2002-05-16
JP2003524186A (ja) 2003-08-12
ES2262627T3 (es) 2006-12-01
EP1257831A2 (en) 2002-11-20

Similar Documents

Publication Publication Date Title
WO2004112168A3 (en) Part tester and method
DE69617464T2 (de) Teststreifen für einen elektochemischen biosensor
GB9804083D0 (en) Immunoassays
DE69822721D1 (de) Vorrichtung für klinische Analysen
TR200001765T2 (tr) Duyguları ayırt etmek için aletler ve yöntemler.
HK1058703A1 (en) Analyte concentration determination meters and methods of using the same
IL159161A0 (en) Functional brain imaging for detecting and assessing deception and concealed recognition, and cognitive/emotional response to information
IN2014DN05011A (da)
WO2003013343A3 (en) Method for psychophysiological detection of deception through brain function analysis
ITRM20030386A1 (it) Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
CA2356442A1 (en) Nmr spectroscopic in vitro assay using hyperpolarization
WO2002082093A3 (en) Methods to measure lipid antioxidant activity
Starkweather Issues in the efficacy of treatment for fluency disorders.
WO2006067792A3 (en) Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease
NO20083610L (no) Cobalamin-maling
AU3498200A (en) An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
WO2003106649A3 (en) CONJUGATE TEST AND USES THEREOF
AU2001233928A1 (en) Cvd assay
WO2001042503A3 (en) Apparatus and methods for drug screening based on nucleic acid analysis
WO2002059600A3 (en) Analyte detection
AU2003276448A1 (en) Quantifying exposure to stress
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
GB0004042D0 (en) Assay
AU2003271668A1 (en) Device for the quantitative determination of an analyte in a sample, and measuring chip for said device
Meric et al. An empirical test of the DeAngelo-Masulis tax shield hypothesis.